Oral Semaglutide Induces Loss of Body Fat Mass Without Affecting Muscle Mass in Patients With Type 2 Diabetes

CONCLUSION: The 24-week treatment with oral semaglutide ameliorated glycemic control with reduction of body fat but not muscle mass in Japanese patients with type 2 diabetes.PMID:37575352 | PMC:PMC10416191 | DOI:10.14740/jocmr4987

Source: Clin Med Res - August 14, 2023 Category: Research Authors: Syutaro Uchiyama Yukiyoshi Sada Syohei Mihara Yosuke Sasaki Masakatsu Sone Yasushi Tanaka Source Type: research